Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil
- PMID: 33234110
- PMCID: PMC7685300
- DOI: 10.1186/s12879-020-05611-5
Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil
Abstract
Background: The State of Ceará, in Northeastern Brazil, suffers from a triple burden of arboviruses (dengue, Zika and chikungunya). We measured the seroprevalence of chikungunya, dengue and Zika and its associated factors in the population of Juazeiro do Norte, Southern Ceará State, Brazil.
Methods: A cross-sectional study of analytical and spatial analysis was performed to estimate the seroprevalence of dengue, Zika and chikungunya, in the year 2018. Participants were tested for IgM and IgG against these three viruses. Those with IgM and/or IgG positive tests results were considered positive. Poisson regression was used to analyze the factors associated with positive cases, in the same way that the spatial analysis of positive cases was performed to verify whether the cases were grouped.
Results: Of the 404 participants, 25.0% (103/404) were positive for CHIKV, 92.0% (373/404) for flavivirus (dengue or Zika) and of these, 37.9% (153/404) samples were classified as probable dengue infection. Of those who reported having had an arbovirus in the past, positive CHIKV cases had 58.7% arthralgia (PR = 4.31; 95% CI: 2.06-9.03; p = 0.000) mainly in the hands, ankles and feet. Age over 60 years had a positive association with cases of flavivirus (PR = 1.29; 95% CI: 1.09-1.54; p = 0.000). Fever, muscle pain, joint pain and skin rash were the most reported symptoms (46.1, 41.0, 38.3 and 28.41%, respectively). The positive cases of chikungunya and dengue or Zika were grouped in space and the city center was most affected area.
Conclusions: Four years after the introduction of CHIKV, where DENV has been in circulation for over 30 years, 1/4 of the population has already been exposed, showing the extent of the epidemic. The measured prevalence was much higher than that reported by local epidemiological surveillance.
Keywords: Chikungunya virus; Dengue virus; Seroprevalence; Zika virus.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil.BMC Infect Dis. 2021 Jul 24;21(1):704. doi: 10.1186/s12879-021-06401-3. BMC Infect Dis. 2021. PMID: 34303348 Free PMC article.
-
Seroprevalence of dengue, Zika, and chikungunya in São Sebastião, Brazil (2020-2021): a population-based survey.BMC Infect Dis. 2025 Jan 27;25(1):129. doi: 10.1186/s12879-025-10516-2. BMC Infect Dis. 2025. PMID: 39871200 Free PMC article.
-
Zika, dengue and chikungunya population prevalence in Rio de Janeiro city, Brazil, and the importance of seroprevalence studies to estimate the real number of infected individuals.PLoS One. 2020 Dec 17;15(12):e0243239. doi: 10.1371/journal.pone.0243239. eCollection 2020. PLoS One. 2020. PMID: 33332373 Free PMC article.
-
Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review.PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006533. doi: 10.1371/journal.pntd.0006533. eCollection 2018 Jul. PLoS Negl Trop Dis. 2018. PMID: 30011271 Free PMC article.
-
The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2021 Apr 28;15(4):e0009337. doi: 10.1371/journal.pntd.0009337. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33909610 Free PMC article.
Cited by
-
Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model.Pathogens. 2022 Feb 25;11(3):294. doi: 10.3390/pathogens11030294. Pathogens. 2022. PMID: 35335618 Free PMC article. Review.
-
High prevalence of dengue, Zika, and chikungunya viruses in blood donors during a dengue outbreak and an endemic period in Colombia.Front Med (Lausanne). 2024 May 1;11:1380129. doi: 10.3389/fmed.2024.1380129. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38751980 Free PMC article.
-
Epidemiology and Economic Burden of Chikungunya: A Systematic Literature Review.Trop Med Infect Dis. 2023 May 31;8(6):301. doi: 10.3390/tropicalmed8060301. Trop Med Infect Dis. 2023. PMID: 37368719 Free PMC article. Review.
-
Chikungunya seroprevalence in population-based studies: a systematic review and meta-analysis.Arch Public Health. 2023 May 1;81(1):80. doi: 10.1186/s13690-023-01081-8. Arch Public Health. 2023. PMID: 37127721 Free PMC article.
-
Dynamics of chikungunya virus transmission in the first year after its introduction in Brazil: A cohort study in an urban community.PLoS Negl Trop Dis. 2023 Dec 27;17(12):e0011863. doi: 10.1371/journal.pntd.0011863. eCollection 2023 Dec. PLoS Negl Trop Dis. 2023. PMID: 38150470 Free PMC article.
References
-
- Cavalcanti LPG, Barreto FKA, Barbosa RMAO, Canuto IFP, Lima AAB, Lima JWO, et al. Thirty years of dengue in Ceará: history, contributions to science and challengesin the current scenario with triple arbovirus circulation. J Health Biol Sci. 2018;6(1):65–82. doi: 10.12662/2317-3076jhbs.v6i1.1415.p65-82.2018. - DOI
-
- BRASIL (2017). Secretaria de Vigilância em Saúde. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo vírus Zika até a Semana Epidemiológica 52, 2016. Volume 48 n 3. Avaliable from: http://portalarquivos.saude.gov.br/images/pdf/2017/fevereiro/05/2017_002.... Accessed 27 Sept 2019.
-
- BRASIL (2018), Ministério da Saúde, Secretaria de Vigilância em Saúde, Boletim Epidemiológico - Monitoramento dos casos de dengue, febre de chikungunya e febre pelo vírus Zika até a Semana Epidemiológica 50, 2017, Vol, 48, N° 45. Avaliable in: http://portalarquivos2.saude.gov.br/images/pdf/2018/maio/28/2018-023.pdf: Accessed 27 Sept 2019.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous